Skip to content

HLS Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    HLS Therapeutics reports fiscal 2019 financial results

    HLS Therapeutics reported financial results for the three- and twelve-month periods ended December 31, 2019, including fiscal-year revenue of $54.2 million and adjusted EBITDA of $31.6 million.